GSK-650394

GSK-650394 has been studied in 1 paper since 2025: none in people yet, 1 review. No study of it in people or animals has been published yet. The newest paper, Jun 7, 2025: “Role of Cellular Senescence in Parkinson's Disease: Potential for Disease-Modification Through Senotherapy”.